COVID-19 & CancerFreeGuest Editorial COVID-Lung Cancer Consortium:An example of how the lung cancer community came together in a challenging time April 24, 2020Vol.46 No.17By Fred R. Hirsch, Paul A. Bunn Jr and John D. Minna
COVID-19 & CancerFreeGuest Editorial When disparities widen: COVID-19 in minority patients with cancer April 24, 2020Vol.46 No.17By Coral Olazagasti and Narjust Florez
Conversation with The Cancer LetterCOVID-19 & CancerFree Berry: “Designing clinical trials doesn’t have high priority when there’s no pandemic. And then, when there’s a pandemic, there’s panic” April 24, 2020Vol.46 No.17By Matthew Bin Han Ong
COVID-19 & CancerFree Remdesivir, IL inhibitors emerge as frontrunners in race to treat COVID-19Phase III results for remdesivir expected within weeks April 24, 2020Vol.46 No.17By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree As COVID-19 peaks in San Antonio, Ruben Mesa predicts gradual reopening April 22, 2020Vol.46 No.17By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Lichtenfeld: COVID-19 exposed weaknesses in the U.S. health care system April 17, 2020Vol.46 No.16By Paul Goldberg
COVID-19 & CancerFreeGuest Editorial Cancer care continues during COVID-19 pandemic—with new tools and old challenges April 17, 2020Vol.46 No.16By Ted Okon
COVID-19 & CancerFreeGuest Editorial Amid COVID-19 pandemic, cancer community responds to fill data gap April 17, 2020Vol.46 No.16By Richard L. Schilsky
COVID-19 & CancerFree American Cancer Society announces a wave of furloughs and layoffs as COVID-19 constricts fundraising April 17, 2020Vol.46 No.16By Alexandria Carolan
COVID-19 & CancerFree As treatments get cancelled because of COVID-19, patients worry about adequacy of care April 17, 2020Vol.46 No.16By Alexandria Carolan
